Vivus Could File Evamist Menopause Spray By Year-End
This article was originally published in The Pink Sheet Daily
Executive Summary
Transdermal estradiol spray significantly reduces hot flashes in Phase III trial.
You may also be interested in...
Vivus Submits NDA For Skin Spray To Treat Hot Flashs
EvaMist would be marketed as a more convenient form of hormone replacement than oral, gel and patch products.
Vivus Submits NDA For Skin Spray To Treat Hot Flashs
EvaMist would be marketed as a more convenient form of hormone replacement than oral, gel and patch products.
Vivus Evamist Menopause Spray To Start Phase III Under Special Protocol Assessment
Firm will conduct single 12-week trial for treatment of moderate to severe vasomotor symptoms with the transdermal estradiol spray. Evamist would be the first estradiol topical spray formulation, Vivus says.